close

Fundraisings and IPOs

1 2 3 73
Number of results: 1453
Date Company Amount Funding type Investors Therapeutic area Type of Information
2021-05-13 Splisense (IL) $28.5 million series B financing round Orbimed (IL) Israel Biotech Fund (IL) Biotel Limited (USA) Integra Holdings (IL) the Cystic Fibrosis Foundation (USA) Rare diseases - Genetic diseases - Pulmonary diseases Series B financing round
2021-05-13 Flare Therapeutics (USA - MA) $82 million series A financing round Third Rock Ventures (USA - MA) Boxer Capital (USA-CA) Nextech Invest (CH) Casdin Capital (USA-NY) Invus Financial Advisors (USA-NY) Eventide Asset Management (USA-MA) Neurological diseases - Inflammatory diseases - Immunological diseases - Rare diseases - Genetic diseases Series A financing round
2021-03-01 SalioGen Therapeutics (USA - MA) $20 Million series A financing round PBM Capital (USA - VA) and other undisclosed investors Cardiovascular diseases - Ophthalmological diseases Series A financing round
2021-02-11 Ensoma (USA - MA) $70 million series A financing round 5AM Ventures (USA – MA) F-Prime Capital (USA – MA) Takeda Ventures (USA – MA) Viking Global Investors (USA – CA) Cormorant Asset Management (USA – MA) RIT Capital Partners (UK) Symbiosis II (USA – MA) Alexandria Venture Investments (USA – CA) Cancer - Oncology - Autoimmune diseases - Infectious diseases Series A financing round
2019-04-08 Sangamo Therapeutics (USA-CA) $136.3 million public offering Private placement
2018-10-18 Oxford Nanopore Technologies (UK) £50 million ( $66 million ) private placement Amgen (USA - CA) Technology - Services Private placement
2018-10-18 Krystal Biotech (USA - PA) $60.0 million private placement Rare diseases - Genetic diseases Private placement
2018-10-17 Iovance Biotherapeutics (USA - CA) $252 million private placement Cancer - Oncology Private placement
2018-10-17 Acticor Biotech (France) € 15.3 million series B financing round Newton BioCapital (Belgium) CapDecisif Management (France) Mirae Capital (South Korea) CMS Medical Venture Investment (China) A&B (China) Cerebrovascular diseases Series B financing round
2018-10-10 Secarna Pharmaceuticals (Germany) grant European Commission’s Horizon 2020 programme Rare diseases - Fibrotic diseases - Lung diseases Grant
2018-10-10 Allogene Therapeutics (USA - CA) $324.0 million IPO Cancer - Oncology IPO
2018-10-10 Allogene Therapeutics (USA - CA) $324 million IPO Cancer - Oncology IPO
2018-10-10 Histogenics (USA - MA) $15.4 million private placement Regenerative Medicine - Bone diseases Private placement
2018-10-10 RoslinCT (UK) Reprocell (UK) £1.2 million grant Innovate UK (UK) Technology - Services Grant
2018-10-05 Epizyme (USA - MA)  $86.25 million private placement Cancer - Oncology - Rare diseases Private placement
2018-10-05 Alligator Bioscience (Sweden) 500 000 SEK (€ 47 845) grant Vinnova, Swedish Governmental Agency for Innovation Systems (Sweden) Cancer - Oncology Grant
2018-09-28 KSQ Therapeutics (USA - MA) $80 million series C financing round Flagship Pioneering (USA - MA) Polaris Partners (USA - MA) ARCH Venture Partners (USA - IL) Alexandria Equities (USA - CA) Baillie Gifford (UK) Cowen Healthcare Investments (USA - NY) Invus (USA - NY) Lilly Asia Ventures (China) Cancer - Oncology - Immunological diseases - Rare diseases Series C financing round
2018-09-26 Minoryx Therapeutics (Spain) €21.3 million series B financing round Chiesi Ventures (Italy) Caixa Capital Risc (Spain) HealthEquity (Spain) Fund+ (Belgium) Idinvest Partners (France) Kurma Partners (France) Sambrinvest (Belgium) Kurma Partners (France) Ysios Capital (Spain) SFPI-FPIM, S.R.I.W Rare diseases Series B financing round
2018-09-20 Fate Therapeutics (USA - CA) private placement Cancer - Oncology - Immunological diseases Private placement
2018-09-20 Y-mAbs Therapeutics (USA - NY) IPO Cancer - Oncology IPO